Your Health, We Care
Release date: 2026-04-16 14:10:47 Article From: Lucius Laos Recommended: 83
Always take Olaparib exactly as your doctor or pharmacist tells you. Olaparib tablets should be swallowed whole with water. Do not chew, crush, dissolve, or split the tablets, as this may affect how quickly the medicine is absorbed into your body. You may take it with or without food. The recommended dosing frequency is twice daily: once in the morning and once in the evening. The usual recommended dose is 300mg (i.e., two 150mg tablets) twice a day, for a total of 4 tablets each day. Be sure to take the full recommended dose every day, continue taking it for as long as your doctor advises, and do not stop on your own.
Your doctor may adjust your dose in the following three situations: First, if you have kidney problems, your doctor may ask you to take 200mg (i.e., two 100mg tablets) twice a day, also a total of 4 tablets per day. Second, if you are taking certain medicines that may affect how Olaparib works (see the interactions section above for details), your doctor will adjust the dose as needed. Third, if you experience certain side effects while taking the medicine (e.g., severe reduction in blood cells), your doctor may temporarily reduce your dose, interrupt treatment for a short period, or permanently stop treatment. Any dose adjustment must be done under your doctor's guidance.
If you forget a dose, do not panic; just take your next dose at the next scheduled time as normal. Do not take a double dose (i.e., two doses at once) to make up for the missed dose. If you think you may have taken an overdose of Olaparib, contact your doctor immediately or go to the nearest hospital. Regarding contraception and pregnancy: Female patients must use two effective methods of contraception during treatment and for 6 months after the last dose, and must undergo regular pregnancy testing before, during, and for 6 months after treatment. Male patients must use condoms during treatment and for 3 months after the last dose, and must not donate sperm. Breastfeeding women must not breastfeed during treatment and for 1 month after the last dose.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：4072025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：5992024-09-07
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combinati···【more】
Recommended：482026-01-06
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：3792025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：3942025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：3742025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：4442025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3602025-01-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
